1. Home
  2. SPCB vs INTS Comparison

SPCB vs INTS Comparison

Compare SPCB & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPCB
  • INTS
  • Stock Information
  • Founded
  • SPCB 1988
  • INTS 2012
  • Country
  • SPCB Israel
  • INTS United States
  • Employees
  • SPCB N/A
  • INTS N/A
  • Industry
  • SPCB Semiconductors
  • INTS Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPCB Technology
  • INTS Health Care
  • Exchange
  • SPCB Nasdaq
  • INTS Nasdaq
  • Market Cap
  • SPCB 53.3M
  • INTS 9.4M
  • IPO Year
  • SPCB N/A
  • INTS 2023
  • Fundamental
  • Price
  • SPCB $9.85
  • INTS $0.30
  • Analyst Decision
  • SPCB Strong Buy
  • INTS Strong Buy
  • Analyst Count
  • SPCB 1
  • INTS 3
  • Target Price
  • SPCB $18.00
  • INTS $8.50
  • AVG Volume (30 Days)
  • SPCB 166.8K
  • INTS 2.5M
  • Earning Date
  • SPCB 08-14-2025
  • INTS 08-07-2025
  • Dividend Yield
  • SPCB N/A
  • INTS N/A
  • EPS Growth
  • SPCB N/A
  • INTS N/A
  • EPS
  • SPCB 1.89
  • INTS N/A
  • Revenue
  • SPCB $27,831,000.00
  • INTS N/A
  • Revenue This Year
  • SPCB $2.73
  • INTS N/A
  • Revenue Next Year
  • SPCB $22.87
  • INTS N/A
  • P/E Ratio
  • SPCB $5.28
  • INTS N/A
  • Revenue Growth
  • SPCB 2.90
  • INTS N/A
  • 52 Week Low
  • SPCB $2.55
  • INTS $0.26
  • 52 Week High
  • SPCB $18.95
  • INTS $5.10
  • Technical
  • Relative Strength Index (RSI)
  • SPCB 51.06
  • INTS 36.77
  • Support Level
  • SPCB $9.61
  • INTS $0.29
  • Resistance Level
  • SPCB $11.14
  • INTS $0.35
  • Average True Range (ATR)
  • SPCB 0.68
  • INTS 0.04
  • MACD
  • SPCB -0.20
  • INTS 0.02
  • Stochastic Oscillator
  • SPCB 35.47
  • INTS 35.10

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: